| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 09/08/2004 | EP1453852A2 Selective urokinase inhibitors |
| 09/08/2004 | EP1453803A2 Tetrahydrocarbozole derivatives as ligands for g-protein coupled receptors (gpcr) |
| 09/08/2004 | EP1191932B1 Production of agglomerates of inogatran and the compound inogatran anhydrate |
| 09/08/2004 | EP1180121B9 Long lasting insulinotropic peptides |
| 09/08/2004 | EP1137662B1 Pharmaceutical compositions comprising quinapril magnesium |
| 09/08/2004 | EP1064021B1 Use of cysteinprotease inhibitors for the manufacture of a medicament for prevention and treatment of brain tissue impairment due to hypertensive encephalopathy or encephalothlipsis. |
| 09/08/2004 | CN1165337C Synthetic cryptophycins |
| 09/08/2004 | CN1165336C Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 09/07/2004 | US6787519 Methods of treating disorders related to apoE |
| 09/07/2004 | CA2093770C Aspartic acid derivatives, their preparation and use |
| 09/02/2004 | WO2004074235A1 Transdermal penetration enhancers |
| 09/02/2004 | WO2004073650A2 Peptidomimetic inhibitors of stat3 activity and their medical uses |
| 09/02/2004 | WO2004052773A3 Peptide nanostructures, methods for their preparation and use |
| 09/02/2004 | WO2003070967A3 Highly homogeneous molecular markers for electrophoresis |
| 09/02/2004 | WO2003063910A3 β-HOMOLYSINE CONJUGATES AND THEIR USE AS TRANSPORT ENHANCER |
| 09/02/2004 | WO2003037933A3 Dermopharmaceutically and cosmetically active oligopeptides |
| 09/02/2004 | US20040171842 VIRICIDES; uSING A SECONDARY AMIDE COMPOUNDAIDS |
| 09/02/2004 | US20040171797 can be implemented with any of the stereoisomers of each of the Lysine (K), Proline (P) or Valine (V) amino acid residues |
| 09/02/2004 | US20040171653 HIV, AIDS; such as 2-[[(dimethylamino)acetyl]amino]-N-[3-[[[(2-hydroxy-1,1-dimethylethyl)amino]sulfonyl](3-methylbutyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-3,3-dimethylbutanamide |
| 09/02/2004 | US20040171572 Complex cationic lipids having quaternary nitrogens therein |
| 09/02/2004 | US20040171555 inhibitors of dipeptidyl peptidase; treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae of diabetes mellitus in mammals |
| 09/02/2004 | US20040171520 Melanocortin receptor-specific peptidomimetics |
| 09/02/2004 | US20040171519 Methanobactin: a copper binding compound having antibiotic and antioxidant activity isolated from methanotrophic bacteria |
| 09/02/2004 | DE10306452A1 New peptides containing tyrosine sulfate, phosphate or sulfonate derivatives, useful against unwanted skin and hair pigmentation and for lightening hair color |
| 09/02/2004 | CA2516685A1 Peptidomimetic inhibitors of stat3 activity and their medical uses |
| 09/01/2004 | EP1452543A2 RGD (ARG-GLY-ASP) coupled to (neuro)peptides |
| 09/01/2004 | EP1452532A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/01/2004 | EP1452182A1 Angiogenesis drugs |
| 09/01/2004 | EP1451209A2 Tetra-,penta-,hexa- and heptapeptides having antiangiogenic activity |
| 09/01/2004 | EP1451208A2 Concentrating aqueous fractions of lisinopril by reverse osmosis |
| 09/01/2004 | EP1451181A1 Dimeric compounds and their use as anti-viral agents |
| 09/01/2004 | EP1450857A2 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 09/01/2004 | EP1450841A2 Tri-, tetra-, and penta-peptides having antiangiogenic activity |
| 09/01/2004 | EP1450840A2 Di-, tri,- and tetra-peptides having antiangiogenic activity |
| 09/01/2004 | EP1303534A4 Promyostatin peptides and methods of using same |
| 09/01/2004 | EP1115738A4 Synthesis of cyclic peptides |
| 09/01/2004 | CN1525979A Bridged bicyclic serine protease inhibitors |
| 09/01/2004 | CN1525978A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/01/2004 | CN1524857A Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 09/01/2004 | CN1164761C Process for producing product contg. antihypertensive tripeptides |
| 09/01/2004 | CN1164611C Synthesizing method for propyl-glutdipeptide |
| 09/01/2004 | CN1164573C Novel alpha-amino acid compound, its preparation process and medicinal composition containing same |
| 08/31/2004 | US6784309 Washing n-(n-(3,3-dimethylbutyl)-l-alpha aspartyl)-l-phenylalanine 1-methyl ester with water; combining with organic solvent to from slurry, filtering to recover purified compound |
| 08/31/2004 | US6784283 Peptide antibiotics |
| 08/31/2004 | US6784201 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 08/31/2004 | US6784158 Method for preparing a compound with growth hormone releasing properties |
| 08/31/2004 | US6784155 Contacting hematopoietic cells with a stem cell proliferation stimulating amount of inprol or an opiate compound or a combination of inprol and an opiate compound |
| 08/31/2004 | US6783958 Generating biosensor protein; determine sequence of fluorescent protein, generate fusion protein, incubate with modulator, detect conformational adjustments, monitor adjustments in fluorescence |
| 08/31/2004 | CA2319150C .alpha.-ketoamide inhibitors of 20s proteasome |
| 08/26/2004 | WO2004072641A1 Compositions and methods for enhancing apoptosis |
| 08/26/2004 | WO2004072243A2 Macrocyclic hepatitis c serine protease inhibitors |
| 08/26/2004 | US20040167337 Boron compounds such as R)-1-{(S)-2-[(S)-2-(biphenyl-3-ylamino)-(3-(3,4,5-trimethoxy-phenyl)-propionylamino]-3-methyl-butyrylamino}-3-methyl-butylboronic acid, used as antitumor or antiproliferative agents |
| 08/26/2004 | US20040167332 Boronic ester and acid compounds, synthesis and uses |
| 08/26/2004 | US20040167201 Pyrrolidine melanocortin-specific compounds |
| 08/26/2004 | US20040167191 Glutaminyl based DPIV inhibitors |
| 08/26/2004 | US20040167116 Viricides |
| 08/26/2004 | US20040167075 Diagnosis, therapy od Alzheimer's disease; blocking psychological conditions |
| 08/26/2004 | US20040167060 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 08/26/2004 | CA2515216A1 Macrocyclic hepatitis c serine protease inhibitors |
| 08/26/2004 | CA2514316A1 Compositions and methods for enhancing apoptosis |
| 08/25/2004 | EP1449842A1 Process for the preparation of pyrazolopyridine tartrates |
| 08/25/2004 | EP1448539A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 08/25/2004 | EP1448218A2 Beta-secretase inhibitors and methods of use |
| 08/25/2004 | EP1353939B1 Tetrapeptide regulating prostate functions and its compositions and uses |
| 08/25/2004 | EP1200457B1 Cysteine protease inhibitors |
| 08/25/2004 | CN1524087A Novel chromogenic substances and use thereof for the determination of carboxypeptidase activities |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1163504C Process for preparing resin-bound cyclic peptide |
| 08/24/2004 | US6781000 Alpha-ketoamide inhibitors of 20S proteasome |
| 08/24/2004 | US6780968 Neurokinin-2 (nk-2) antagonists useful in the treatment or prevention of disorders of the central nervous system, inflammatory diseases, asthma, or pain |
| 08/24/2004 | US6780848 Use of GPE to protect glial cells or non-dopaminergic cells from death from neural injury or disease |
| 08/24/2004 | CA2290252C Process and intermediates for growth hormone secretagogues |
| 08/19/2004 | WO2004070054A2 Methods for preventing mitochondrial permeability transition |
| 08/19/2004 | WO2004069276A1 Drug for preventing, regulating or treating adhesion |
| 08/19/2004 | WO2004069200A2 Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases |
| 08/19/2004 | WO2004069182A2 Active immunization to generate antibodies to soluble a-beta |
| 08/19/2004 | WO2004050620A3 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 08/19/2004 | WO2003089607A3 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 08/19/2004 | WO2002068601A3 Small peptides capable of modulating the function of cd66 (ceacam) family members |
| 08/19/2004 | US20040162410 Thrombosis therapy; anticoagulants |
| 08/19/2004 | US20040162261 Double chain compound having an amino group and a carboxyl group in the hydrophilic part; forms a stable bilayer membrane vesicle in water, and a water-soluble drug can be enclosed in the internal phase of the vesicle at high efficiency |
| 08/19/2004 | US20040162244 Novel peptides use as angiotensin converting enzyme inhibitor and preparation process thereof |
| 08/19/2004 | US20040161383 Diagnostic agents for pancreatic exocrine function |
| 08/19/2004 | DE10305531A1 New tubulysin compound conjugates with polymers or biomolecules, having reduced toxicity compared with parent tubulysin, especially useful for treating tumor diseases |
| 08/19/2004 | CA2513722A1 Active immunization to generate antibodies to soluble a-beta |
| 08/18/2004 | EP1447409A1 Crystal of oxidized glutathione and process for producing the same |
| 08/18/2004 | EP1447398A1 Retroviral protease inhibitors |
| 08/18/2004 | EP1446665A2 Isotopically coded affinity markers 3 |
| 08/18/2004 | EP1446418A2 Integrin targeting compounds |
| 08/18/2004 | EP1446392A1 Oligopeptides and compositions containing them as cathepsin s inhibitors |
| 08/18/2004 | EP1325026B1 Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use |
| 08/18/2004 | EP1140837B1 Compounds useful in the treatment of inflammatory diseases |
| 08/18/2004 | EP1117676B1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 08/18/2004 | EP1087935B1 Anthracene derivatives as anti-cancer agents |
| 08/18/2004 | EP0702674B1 Process for the synthesis of peptides using protecting and anchor groups |
| 08/17/2004 | US6777577 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 08/17/2004 | US6777550 N-formyl hydroxylamine containing compounds useful as ACE inhibitors and/or NEP inhibitors |
| 08/17/2004 | US6777443 For therapy of cardiovascular disorders in mammals; for inhibiting both angiotensin converting enzyme and neutral endopeptidase in mammals |
| 08/17/2004 | US6777403 Method and structure for inhibiting activity of serine elastases |
| 08/17/2004 | US6777217 Genes which are involved in the control of chromatin structure and, thus in transcription and translation; used to control cell proliferation and differentiation in vitro and in vivo |